论文部分内容阅读
目的观察头孢西丁序贯疗法和常规疗法治疗儿童获得性肺炎的疗效,探讨头霉菌素序贯疗法的可行性和优势所在,为合理使用抗生素提供依据。方法将120例符合肺炎诊断标准的门诊留观病例随机分为2组,治疗组60例,头孢西丁静脉滴注2～3d后改为头孢克肟颗粒口服5～7d;对照组60例,始终头孢西丁静脉滴注7～10d。结果治疗组总显有效率93.33%,对照组总显有效率96.67%,治疗组和对照组疗效无显著性差异,但门诊治疗时间和抗生素费用明显低于对照组。结论头霉菌素序贯疗法治疗儿童支气管肺炎经济、有效。
Objective To observe the curative effect of sequential treatment of cefoxitin and routine therapy in children with acquired pneumonia and to explore the feasibility and advantages of sequential therapy of cephalosporin and provide a basis for rational use of antibiotics. Methods One hundred and twenty cases of obstructive pulmonary disease were enrolled in this study. The patients in the treatment group were randomly divided into two groups. 60 cases in the treatment group were treated with cefoxitin intravenously for 2 to 3 days, and then cefixime granules for 5-7 days. In the control group, Always cefoxitin intravenous infusion of 7 ~ 10d. Results The total effective rate was 93.33% in the treatment group and 96.67% in the control group. There was no significant difference between the treatment group and the control group, but the outpatient treatment time and the antibiotic expense were significantly lower than those in the control group. Conclusions Cefotynil sequential therapy is effective and cost-effective in treating bronchial pneumonia in children.